 |
|
Experts Focus on Infective Agents of Bioterrorism
Joan Stephenson, PhD
JAMA. 2002;287:575-576.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Chicago—Bioterrorism is on the minds of infectious disease specialists these days. And as many gathered here at the Interscience Conference on Antimicrobial Agents and Chemotherapy, the topic took on a new urgency in the wake of recent deaths and illness caused by anthrax-laced mail.
Smallpox Vaccine Potency Tested
One of the most feared potential bioterrorist agents is smallpox, which was declared eradicated in nature in 1980. Because routine vaccinations ended in the United States in 1972, leaving the vast majority of people vulnerable to a deliberate release of smallpox by bioterrorists, the federal government has ordered 209 million doses of smallpox vaccine from a British company.
| |
Growing concerns that smallpox virus—the cause of these lesions on a patient in Bangladesh in 1973—could become a bioterrorist weapon has health experts scrambling to expand vaccine supplies. (Photo credit: CDC/James Hicks)
|
|
But the vaccine is not expected to be . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
In Vitro Efficacy of New Antifolates against Trimethoprim-Resistant Bacillus anthracis
Barrow et al.
Antimicrob. Agents Chemother. 2007;51:4447-4452.
ABSTRACT
| FULL TEXT
Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre(R) automated microbroth dilution and Etest(R) agar gradient diffusion methods
Luna et al.
J Antimicrob Chemother 2007;60:555-567.
ABSTRACT
| FULL TEXT
Functional Cloning of Bacillus anthracis Dihydrofolate Reductase and Confirmation of Natural Resistance to Trimethoprim
Barrow et al.
Antimicrob. Agents Chemother. 2004;48:4643-4649.
ABSTRACT
| FULL TEXT
|
